HIV PRE-EXPOSURE PROPHYLAXIS
Clinical trials for HIV PRE-EXPOSURE PROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS trials appear
Sign up with your email to follow new studies for HIV PRE-EXPOSURE PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New monthly pill could revolutionize HIV prevention for women
Prevention Recruiting nowThis study is testing whether a new monthly oral pill called MK-8527 works better than standard daily medication to prevent HIV infection in women. It will involve about 4,580 HIV-negative women who are at risk of getting HIV through sex. The main goals are to see if the monthly …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Apr 03, 2026 19:55 UTC
-
New community approach to HIV prevention shows promise
Prevention Recruiting nowThis study tests whether delivering a long-acting injectable HIV prevention medication (lenacapavir) through a trusted community organization helps Latine gay/bisexual men and transgender women stay on the medication longer. Researchers will work with El Centro Hispano to provide…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated Apr 03, 2026 14:43 UTC
-
One shot a year to stop HIV? major trial tests new prevention method
Prevention Recruiting nowThis study is testing a new drug called lenacapavir, given as a single injection once a year, to see if it can safely prevent HIV infection in people who are at risk. The main goals are to measure how much of the drug stays in the body over a year and to check for any side effect…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Prevention
Last updated Apr 03, 2026 14:41 UTC
-
Monthly HIV prevention pill could replace daily medication
Prevention Recruiting nowThis study is testing whether a new monthly oral pill called MK-8527 works as well as or better than standard daily PrEP medication to prevent HIV infection. The trial will involve 4,390 HIV-negative adults at risk of HIV exposure. Researchers will compare how effective the month…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Mar 20, 2026 14:48 UTC